These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis. Kanteti R, Miller K, McCann J, Roitman D, Morelli J, Hurley C, Berkman E, Schenkein D. Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930 [Abstract] [Full Text] [Related]
4. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Dreger P, Klöss M, Petersen B, Haferlach T, Löffler H, Loeffler M, Schmitz N. Blood; 1995 Nov 15; 86(10):3970-8. PubMed ID: 7579368 [Abstract] [Full Text] [Related]
5. How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term? Zinzani PL, Martelli M, Magagnoli M, Zaja F, Storti S, Pavone E, Lauta VM, De Renzo A, Gobbi M, Bocchia M, Ronconi F, Scaramucci L, Gherlinzoni F, Palombi F, Bendandi M, Stefoni V, Anticoli Borza P, Cellini C, Mandelli F, Tura S. Haematologica; 1999 Nov 15; 84(11):996-1001. PubMed ID: 10553159 [Abstract] [Full Text] [Related]
8. Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation. Schouten HC, Armitage JO, Klassen LW, Vaughan WP, Bierman PJ, Weisenburger D, Kessinger A. Bone Marrow Transplant; 1989 Jan 15; 4(1):119-21. PubMed ID: 2466510 [Abstract] [Full Text] [Related]
9. Correlation of CD34+ cell yield in peripheral blood progenitor cell product with the pre-leukapheresis cell counts in peripheral blood. Sawant RB, Rajadhyaksha SB. J Assoc Physicians India; 2005 Dec 15; 53():1031-5. PubMed ID: 16572958 [Abstract] [Full Text] [Related]
10. Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma. Martín A, Pérez-Simón JA, Caballero MD, López-Holgado N, Vázquez L, del Cañizo MC, San Miguel JF. Haematologica; 2005 Jan 15; 90(1):78-85. PubMed ID: 15642673 [Abstract] [Full Text] [Related]
14. Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients: effect of a brief course of G-CSF on harvest and recovery. Damiani D, Grimaz S, Infanti L, Sperotto A, Silvestri F, Geromin A, Cerno M, Savignano C, Michieli M, Skert C, Fanin R, Baccarani M. Bone Marrow Transplant; 1999 Oct 15; 24(7):757-61. PubMed ID: 10516679 [Abstract] [Full Text] [Related]
18. Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation. Demirkazik A, Kessinger A, Armitage JO, Bierman PJ, Lynch J, Vose J, Chan W, Sharp JG. Bone Marrow Transplant; 2001 Jul 15; 28(2):207-12. PubMed ID: 11509940 [Abstract] [Full Text] [Related]
19. The F-MACHOP regimen in the treatment of aggressive non-Hodgkin's lymphomas: a single center experience in 72 patients. Infanti L, Silvestri F, Fanin R, Salmaso F, Zaja F, Barillari G, Patriarca F, Geromin A, Cerno M, Damiani D, Baccarani M. Haematologica; 1996 Jul 15; 81(6):521-8. PubMed ID: 9009439 [Abstract] [Full Text] [Related]
20. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Hausdorff J, Davis E, Long G, Hoppe R, van der Pas M, Lassman C, Kamel O, Jacobs C. Cancer J Sci Am; 1997 Jul 15; 3(5):303-11. PubMed ID: 9327155 [Abstract] [Full Text] [Related] Page: [Next] [New Search]